My good friend Oliver! Thank you for your long persistance! We have tried to work this cohort from every angel. We have just not seen that mitomycin is superior to oxaliplatin in any subgroup. Prodige 7 made centers switch to mitomycin, but we just don’t have the data for switch

Pls read this excellent commentary by Beate Rau. She nails the topic&issues on the head. #HIPEC should be delivered at a minimum in a registry but even better trial setting as the effects are unclear. Markus W. Löffler, MD & I have written about this in the past doi.org/10.1007/s12254…

Hyperthermic intraperitoneal chemotherapy in colorectal cancer
➡️doi.org/10.1093/bjsope…

This is a large multicentric global study combining a number of large national peritoneal surface oncology databases from three continents (39 centres) for evaluating the use and choice of…

Our updated guideline for FAP, MAP and other polyposis syndromes is published BJS

A huge effort by Gabriela Moeslein and Gloria Zaffaroni. It was a pleasure to work with you.

When do we get a liver perfusion machine that can be transported to donor hospital by plane?

Are you are surgical resident? Located in Europe? Time to save the date for the next year’s legendary DAVOS course. See you there!

Ever wonder what it's like to be an editor for BJS?🖋️
➡️bit.ly/49SlRAf

👂Listen in as Professor Kjetil Soreide discusses just that. This video is first up in our exciting new series ‘Editing in Surgery’, featuring course videos from our BJS Institute partnership…

💥💥Competing risk analysis onage, comorbidities and relevant changes in IPMN under surveillance Gut Journal💥💥

Giovanni Marchegiani Gabriele Capurso MD, PhD🇺🇦 EPC-Europ Pancr Club AISP IHPBA E-AHPBA SoMe4HPB AICEP YOUPPIE Pancreas PanCAN OncoAlert PancreasGroup.org

gut.bmj.com/content/early/…

Narrative review summarizes left-sided diverticulitis pathophysiology, advances in diagnosis, prevention strategies, and surgical approaches and decision-making. ja.ma/3vY6Rmy

Still 10 days left to apply!

Would you like to learn from stellar teams of BJS / BJS Open / BJS Academy?

Is there something you would like to bring to the table of academic publishing?

This is YOUR chance!

ESSO Advanced course on #PancreaticCancer ▶️ From diagnosis to complications management, this course covers it all. Don't miss your chance to learn from experts in 📍 Milan, IT on 📅 September 12-13, 2024. Reserve your spot today!
👉 buff.ly/4aiAlu3

Our latest paper is out!

Reoperation risk and cumulative burden of complications higher in low-volume hospitals↗️, whereas failure to rescue (FTR) remained similar 🟰 in elective colorectal surgery

Impact of hospital volume on failure to rescue for complications requiring reoperation after elective colorectal surgery: multicentre propensity score–matched cohort study
➡️doi.org/10.1093/bjsope…

This population-based retrospective multicentre cohort study compared results…

#polltime How do failure-to-rescue (FTR = mortality for any cause within 90 days after a reoperation) and reoperation rates differ in low-volume (LVHs) vs high-volume hospitals (HVHs) following elective colorectal surgery?

#SoMe4Surgery #MedTwitter #SurgEd #Surgery SoMe4Surgery…

Congratulations to RehamBaamer on passing defending her PhD thesis with flying colours. One of my best students. Papers already published in 𝘈𝘯𝘢𝘦𝘴𝘵𝘩𝘦𝘴𝘪𝘢 BJS Open and British Journal of Anaesthesia

Great day for our research program on #thrombosis & #bleeding in #surgery

Large, investigator-initiated, international #ARTStrial approved in Finland 🇪🇺 by ethics & regulators

We’ill do best to recruit patients & improve care #EBM #thromboprophylaxis

Contact if interested!

If you interested in large #thromboprophylaxis trial of > 5,000 patients and at the #EAU24 @uroweb meeting, come Sunday April 7 at 6:30pm to EGPT area and let's chat! #ARTStrial #EBM Veeru Kasi BURST Urology Tuomas Kilpeläinen Philippe Violette Shomik Sengupta Aleksandra Rautio PHRI.ca Population Health Research Institute 🇨🇦

ProScreen trial results presented at the EAU24 now and simultaneously published in JAMA. jamanetwork.com/journals/jama/…

Results of #HELIX trial presented at #AHPBA24 by Paul Karanicolas: TXA vs placebo for hepatectomy

1⃣3⃣8⃣4⃣pts
No difference in primary outcome of🩸transfusion
But increased complications (related to VTE)

TXA not for use in hepatectomy⚠️

In NEJM today - long awaited results of the SENOMAC trial: nej.md/3PNRGD9 👍🏻 European Society of Surgical Oncology (ESSO) ASBrS Svensk Kirurgi, tidning Breast Snippets Cancerfonden Bröstcancerförbundet